U
CaliPharms, Inc. KGET
$0.00 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

09/30/2014 06/30/2014 03/31/2014
Revenue -- -- --
Total Other Revenue -- -- --
Total Revenue -- -- --
Cost of Revenue -- -- --
Gross Profit -- -- --
SG&A Expenses 21.46% 208.57% 149.17%
Depreciation & Amortization -- -- --
Other Operating Expenses -- -- --
Total Operating Expenses 57.99% 305.33% 168.03%
Operating Income -25.53% -242.67% -153.18%
Income Before Tax -2,161.95% -2,375.47% -493.94%
Income Tax Expenses -- -- --
Earnings from Continuing Operations -2,161.95% -2,375.47% -493.94%
Earnings from Discontinued Operations -- -- --
Extraordinary Item & Accounting Change -- -- --
Minority Interest in Earnings -- -- --
Net Income -2,161.95% -2,375.47% -493.94%
EBIT -25.53% -242.67% -153.18%
EBITDA -- -- --
EPS Basic -- -- --
Normalized Basic EPS -- -- --
EPS Diluted -- -- --
Normalized Diluted EPS -- -- --
Average Basic Shares Outstanding -- -- --
Average Diluted Shares Outstanding -- -- --
Dividend Per Share -- -- --
Payout Ratio -- -- --
Weiss Ratings